ARAV Shares Outstanding History
Below is a table of the ARAV shares outstanding history going back to 10/16/2018:

Date ARAV Shares Outstanding
10/16/20186.04M
10/31/201811.18M
3/8/201911.28M
4/29/201911.28M
5/2/201911.28M
8/1/201911.28M
12/31/201827.18M
10/29/201911.31M
3/16/202015.02M
5/1/202015.95M
7/28/202016.02M
10/30/202016.09M
3/10/202119.66M
5/3/202120.39M
7/31/202120.71M
10/25/202120.97M
3/25/202221.09M
5/6/202228.83M
8/8/202230.52M
11/4/202259.83M

Also see: ARAV Market Cap History
ARAV YTD Return
ARAV Historical Shares Outstanding:
+76.03% CAGR
ARAV Historical Shares Outstanding: +76.03% CAGR

Mouse over chart for data details
10/16/2018 ...11/4/2022
Aravive is a clinical-stage biopharmaceutical company developing treatments designed to halt the progression of diseases, including cancer and fibrosis. Co.'s primary product candidate, batiraxcept, is a decoy protein that targets the GAS6-AXL signaling pathway. By capturing serum GAS6, batiraxcept starves the AXL pathway of its signal, potentially halting the biological programming that promotes disease progression. AXL receptor signaling plays a role in multiple types of malignancies by promoting metastasis, cancer cell survival, resistance to treatments, and immune suppression. We show 20 historical shares outstanding datapoints in our coverage of ARAV's shares outstanding history.

Understanding the changing numbers of ARAV shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ARAV versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ARAV by allowing them to research ARAV shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree ARAV Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Aravive (ARAV) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

ARAY Shares Outstanding History
ARCT Shares Outstanding History
ARDM Shares Outstanding History
ARDS Shares Outstanding History
ARDX Shares Outstanding History
ARMO Shares Outstanding History
ARNA Shares Outstanding History
ARPO Shares Outstanding History
ARQL Shares Outstanding History
ARQT Shares Outstanding History
More Healthcare companies »

 

ARAV Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2022, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.